The Journal of Immunology, Vol 144, Issue 3 790-795, Copyright © 1990 by American Association of Immunologists

ARTICLES

CD4+ T cell-mediated killing of MHC class II-positive antigen- presenting cells. I. Characterization of target cell recognition by in vivo or in vitro activated CD4+ killer T cells

P Erb, D Grogg, M Troxler, M Kennedy and M Fluri
Institute for Medical Microbiology, University of Basel, Switzerland.

Ag-specific as well as Ia-restricted killing of certain APC by CD4+ T cells was investigated. The CD4-mediated killing is not only a characteristic of in vitro long term cultured T cell lines or clones, but is also manifest after in vivo priming. Thus, CD4+ killer T cells are generated in vivo as well. CD4+ killer T cells are detected in the Th1, but not in the Th2 subset, and they do not appear to lyse Ia+ APC or bystander cells by a pathway mediated by secreted T cell factors. The latter observation is demonstrated by cold target inhibition experiments as well as by the failure of puromycin to inhibit killing, if applied in doses which completely block lymphokine secretion. Ia+ APC differ in their susceptibility to lysis. Transformed APC are usually better lysed than nontransformed APC. Unstimulated B cells are not killed, while LPS-stimulated B cell blasts are killed. The results of cold target inhibition and bystander killing experiments suggest that CD4+ killer T cells are activated by the common pathway, i.e., by Ag presented in the context of Ia, but killing requires the recognition of additional determinant(s) on APC. It is proposed that these killing- inducing determinants are continuously expressed on most transformed Ia+ cells and on nontransformed but stimulated APC.

This article has been cited by other articles:

				C. S. Umeshappa, H. Huang, Y. Xie, Y. Wei, S. J. Mulligan, Y. Deng, and J. Xiang CD4+ Th-APC with Acquired Peptide/MHC Class I and II Complexes Stimulate Type 1 Helper CD4+ and Central Memory CD8+ T Cell Responses J. Immunol., January 1, 2009; 182(1): 193 - 206. [Abstract] [Full Text] [PDF]

				E. R. Jellison, S.-K. Kim, and R. M. Welsh Cutting Edge: MHC Class II-Restricted Killing In Vivo during Viral Infection J. Immunol., January 15, 2005; 174(2): 614 - 618. [Abstract] [Full Text] [PDF]

				B. Livingston, C. Crimi, M. Newman, Y. Higashimoto, E. Appella, J. Sidney, and A. Sette A Rational Strategy to Design Multiepitope Immunogens Based on Multiple Th Lymphocyte Epitopes J. Immunol., June 1, 2002; 168(11): 5499 - 5506. [Abstract] [Full Text] [PDF]

				T. Cao, P. Meuleman, I. Desombere, M. Sallberg, and G. Leroux-Roels In Vivo Inhibition of Anti-Hepatitis B Virus Core Antigen (HBcAg) Immunoglobulin G Production by HBcAg-Specific CD4+ Th1-Type T-Cell Clones in a hu-PBL-NOD/SCID Mouse Model J. Virol., December 1, 2001; 75(23): 11449 - 11456. [Abstract] [Full Text]

				M. Iwashiro, K. Peterson, R. J. Messer, I. M. Stromnes, and K. J. Hasenkrug CD4+ T Cells and Gamma Interferon in the Long-Term Control of Persistent Friend Retrovirus Infection J. Virol., January 1, 2001; 75(1): 52 - 60. [Abstract] [Full Text]

				D. v. Essen, P. Dullforce, T. Brocker, and D. Gray Cellular Interactions Involved in Th Cell Memory J. Immunol., October 1, 2000; 165(7): 3640 - 3646. [Abstract] [Full Text] [PDF]

				S. M. Krams, M. Hayashi, C. K. Fox, J. C. Villanueva, K. J. Whitmer, W. Burns, C. O. Esquivel, and O. M. Martinez CD8+ Cells Are Not Necessary for Allograft Rejection or the Induction of Apoptosis in an Experimental Model of Small Intestinal Transplantation J. Immunol., April 15, 1998; 160(8): 3673 - 3680. [Abstract] [Full Text] [PDF]

				S. Nakao, A. Takami, H. Takamatsu, W. Zeng, N. Sugimori, H. Yamazaki, Y. Miura, M. Ueda, S. Shiobara, T. Yoshioka, et al. Isolation of a T-Cell Clone Showing HLA-DRB1*0405-Restricted Cytotoxicity for Hematopoietic Cells in a Patient With Aplastic Anemia Blood, May 15, 1997; 89(10): 3691 - 3699. [Abstract] [Full Text] [PDF]